| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/20/2008 | EP1888728A1 Fatty acid analogues, i.e. dha derivatives for uses as a medicament |
| 02/20/2008 | EP1888727A1 New dha derivatives and their use as medicaments |
| 02/20/2008 | EP1888582A1 Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i |
| 02/20/2008 | EP1888571A2 New salt and polymorphs of a dpp-iv inhibitor |
| 02/20/2008 | EP1888562A2 Dipeptidyl peptidase-iv inhibitors |
| 02/20/2008 | EP1888513A1 Novel trifluoromethoxy-substituted aryl anilides |
| 02/20/2008 | EP1888173A2 Novel use of (-)-epigallocatechin gallate |
| 02/20/2008 | EP1888102A2 Modulation of peripheral clocks in adipose tissue |
| 02/20/2008 | EP1888066A2 Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/20/2008 | EP1888059A2 Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomakers |
| 02/20/2008 | EP1887891A1 Dietary fiber composition comprising glucomannan, xanthan gum, and alginate |
| 02/20/2008 | EP1672988A4 Weight-loss supplement |
| 02/20/2008 | EP1620423B1 Process for the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof |
| 02/20/2008 | EP1448561B1 Beta 3 adrenergic agonists |
| 02/20/2008 | EP1424907B1 Oil composition |
| 02/20/2008 | EP1408966B1 Synergistic pharmaceutical combinations for the prevention or treatment of diabetes |
| 02/20/2008 | EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 02/20/2008 | EP1354871B1 Biphenyl derivatives |
| 02/20/2008 | EP1333846A4 Preparation and xenotransplantation or porcine islets |
| 02/20/2008 | EP1305310B1 Tartrate salts of thiazolidinedione derivative |
| 02/20/2008 | CN101128487A Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY |
| 02/20/2008 | CN101128485A Monoclonal antibodies against angiopoietin-like protein 4 (ANGPTL4) |
| 02/20/2008 | CN101128451A Derivatives of n-[(4,5-diphenyl-2-thienyl)methyl]amine, their preparations and therapeutic application |
| 02/20/2008 | CN101128438A Substituted 1,1,1-trifluoro-3-[(benzyl)-(pyrimidin-2-yl)-amino]-prop an-2-ol compounds |
| 02/20/2008 | CN101128418A Diastereoisomers of 4-hydroxyisoleucine and uses thereof |
| 02/20/2008 | CN101128213A Promoter of regeneration of pancreatic beta cell, and promoter of insulin production in pancreatic beta cell |
| 02/20/2008 | CN101128211A Aloe vera extract, process for production of aloe vera extract, and ameliorating agent for hyperglycemia |
| 02/20/2008 | CN101128192A Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
| 02/20/2008 | CN101125882A Recombination PAC1 receptor agonist RMMAX and its expression method and application |
| 02/20/2008 | CN101125881A Recombination PAC1 receptor antagonist D(25-44)RMMAX and its expression method and application |
| 02/20/2008 | CN101125880A Bindwood sapogenin and its preparation method and use |
| 02/20/2008 | CN101125864A Heteroaromatic inhibitor for fructose-1,6-bisphosphatase |
| 02/20/2008 | CN101125853A Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 02/20/2008 | CN101125852A Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 02/20/2008 | CN101125851A Novel pharmaceutical |
| 02/20/2008 | CN101125850A Andrographolide derivatives and application of the same in pharmacy |
| 02/20/2008 | CN101125788A Method for preparing apple polyphenol and nourishment hardening agent |
| 02/20/2008 | CN101125207A Exendin or its analogs with polyethylene group and its preparation and application |
| 02/20/2008 | CN101125182A Lipid-lowering weight-reducing face-nourishing capsule and preparation method |
| 02/20/2008 | CN101125177A Fermented glutinous wine for treating diabetes |
| 02/20/2008 | CN101125173A Traditional Chinese medicine 'guiyuantangkang' for treating diabetes and its complication |
| 02/20/2008 | CN101125164A Blood-pressure-lowering and blood-lipid-lowering compound apocynum leaf solid preparation and preparation method thereof |
| 02/20/2008 | CN101125154A Raidx cynanchum bungei decne glycoside of mountain Tai and preparation method thereof |
| 02/20/2008 | CN101125152A 纳米级有机硒 Nanoscale organic selenium |
| 02/20/2008 | CN101125144A Compound medicine for treating diabetes |
| 02/20/2008 | CN101125139A Application of procyanidin B2 in preparing medicine for preventing and treating diabetes and vascular complication |
| 02/20/2008 | CN101125133A Unsaturated fatty acid microcapsule preparing technology and application |
| 02/20/2008 | CN100369919C Tricyclic protein kinase inhibitors |
| 02/20/2008 | CN100369898C Nicotinamide derivates useful as p38 inhibitors |
| 02/20/2008 | CN100369894C Nitric oxide synthase inhibitor phosphate salt |
| 02/20/2008 | CN100369891C HIF hydroxylase inhibitors |
| 02/20/2008 | CN100369610C Plant extract for preventing and treating diabetes, and preparing method and pharmaceutic use thereof |
| 02/20/2008 | CN100369605C Blood lipid ameliopant composition |
| 02/20/2008 | CN100369558C Edible oil palm fibre powder ,food containing the same and production method |
| 02/19/2008 | US7332610 Chemical intermediates for production of sibutramine |
| 02/19/2008 | US7332524 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/19/2008 | US7332521 Substituted indoles |
| 02/19/2008 | US7332517 1-(1H-indol-3-ylmethyl)-3-(4-nitrophenyl)-5-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]-2thioxo-4imidazolidinone; somastatin receptor affinity; acromegaly, hypophyseal adenomas, endocrine gastroenteropancreatic tumors, as carcinoid syndrome and gastrointestinal bleeding |
| 02/19/2008 | US7332515 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity |
| 02/19/2008 | US7332514 Dibenzylamine compound and medicinal use thereof |
| 02/19/2008 | US7332507 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 02/19/2008 | US7332497 Pyrazolopyrimidines as therapeutic agents |
| 02/19/2008 | US7332492 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by NP Y5 receptor |
| 02/19/2008 | US7332487 Nitrogen-containing 5-membered ring compound |
| 02/19/2008 | US7332301 Insulin-like growth factor binding protein |
| 02/19/2008 | US7332185 Component I selected from alpha acids and beta acids and component II selected from alpha acids, beta acids, essential oils, fats and waxes; specific inhibition of cyclooxygenase-2 with little effect on cyclooxygenase-1 |
| 02/19/2008 | US7332184 Colonic cleansing composition and method |
| 02/19/2008 | CA2481723C 5ht2c receptor modulators |
| 02/19/2008 | CA2237023C Improved formulation for administration of steroid compounds |
| 02/19/2008 | CA2206366C Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 02/19/2008 | CA2197210C Intravenous alendronate formulations |
| 02/19/2008 | CA2173976C Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 02/14/2008 | WO2008019368A2 Albumin-insulin fusion proteins |
| 02/14/2008 | WO2008019346A2 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
| 02/14/2008 | WO2008019143A2 Use of exendins and glp-i receptor agonists for altering lipoprotein particle size and subclass composition |
| 02/14/2008 | WO2008018641A1 Monoclonal antibodies against stromal derived factor-1 (sdf-1) |
| 02/14/2008 | WO2008018638A1 Fat absorption inhibitor and food and drink using the same |
| 02/14/2008 | WO2008018556A1 Tablet |
| 02/14/2008 | WO2008018529A1 Novel pyrimidine compound having benzyl(pyridylmethyl)amine structure and pharmaceutical comprising the compound |
| 02/14/2008 | WO2008018472A1 Novel monoclonal antibody and use of the same |
| 02/14/2008 | WO2008018448A1 Activator comprising biosurfactant as the active ingredient, mannosyl erythritol lipid and method of producing the same |
| 02/14/2008 | WO2008018427A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 02/14/2008 | WO2008018371A1 Oral disintegrating tablet having masked bitter taste and method for production thereof |
| 02/14/2008 | WO2008018306A1 Quinazoline derivative |
| 02/14/2008 | WO2008018275A1 Anti-obesity agent and use thereof |
| 02/14/2008 | WO2008018139A1 Antiobesity composition containing component originating in the bark of tree belonging to the genus acacia |
| 02/14/2008 | WO2008018138A1 Hypoglycemic composition containing component originating in the bark of tree belonging to the genus acacia |
| 02/14/2008 | WO2008018133A1 Moisturizing agent, cell-activating agent, skin-whitening agent, agent for suppressing triglyceride accumulation, antioxidant and external preparation for skin |
| 02/14/2008 | WO2008018089A1 R-(-) / s-(+)-7-[3-n-substituted amino-2-hydroxypropoxy] flavones |
| 02/14/2008 | WO2008017886A1 Novel hydrate form of o-desmethyl venlafaxine succinate |
| 02/14/2008 | WO2008017752A2 Eucalyptus extract, method of preparation and therapeutic uses thereof |
| 02/14/2008 | WO2008017161A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 02/14/2008 | WO2008003067A3 Methods and compositions for improved uptake of biological molecules |
| 02/14/2008 | WO2008000950A3 Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use |
| 02/14/2008 | WO2007018248A9 Pyridone compound |
| 02/14/2008 | WO2006024627A9 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/14/2008 | US20080039525 Lipid System and Methods of Use |
| 02/14/2008 | US20080039514 anticholesterol agents; 2-Methyl-2-{3-[3-(4-trifluoromethyl-phenyl)-benzo[d]isoxazol-6-yloxy]-phenoxy}-propionic acid; associated with atherosclerosis and non-insulin dependent diabetes |
| 02/14/2008 | US20080039478 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof |
| 02/14/2008 | US20080039465 Triazolyl phenyl benzenesulfonamides |